Pseudomonas Aeruginosa Infection in Respiratory Samples in Children with Neurodisability – to treat or not to treat?

E. Gregson (Sheffield (South Yorkshire), United Kingdom), L. Thomas (Sheffield (South Yorkshire), United Kingdom), K. Auton (Cambridgeshire, United Kingdom), H. Elphick (Sheffield (South Yorkshire), United Kingdom)

Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children
Session: Aspects of acute and chronic airway infections in children
Session type: Oral Presentation
Number: 4654
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Gregson (Sheffield (South Yorkshire), United Kingdom), L. Thomas (Sheffield (South Yorkshire), United Kingdom), K. Auton (Cambridgeshire, United Kingdom), H. Elphick (Sheffield (South Yorkshire), United Kingdom). Pseudomonas Aeruginosa Infection in Respiratory Samples in Children with Neurodisability – to treat or not to treat?. 4654

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Primary ciliary dyskinesia: Respiratory tract infections and impact of pseudomonas aeruginosa
Source: International Congress 2014 – Respiratory physiology and sleep disordered breathing in children
Year: 2014


Do we treat mycoplasma pneumoniae infections differently during an epidemic?
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Pseudomonas aeruginosa pneumonia in the community
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Rhinosinusitis in children: Seasonality and etiology
Source: International Congress 2014 – Respiratory infections in children
Year: 2014

Resistance of respiratory isolates of klebsiella pneumoniae from patients in pediatric cardiac surgery department
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016


Aminoglycoside use for pseudomonas aeruginosa in bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Respiratory viruses' coinfection in children with B. pertussis
Source: International Congress 2014 – Virus-triggered lower respiratory disease in children
Year: 2014


Extended-spectrum-beta-lactamase producing multidrug resistant nosocomial bacterial isolates causing lower respiratory tract infection in Tertiary Care Hospital, Nepal
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video
Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video
Year: 2014

Multidrug resistant acinetobacter baumanii pneumonia: Mortality analysis and comparison of intravenous versus aerosolized therapy
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Bacterial colonization in patients with bronchiectasis
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


Community adquired legionella pneumophila pneumonia in elderly patients
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

Antibiotics to treat Community-acquired Lower Respiratory Tract Infections: mechanism of action, spectrum, epidemiology resistance.
Source: Value-Dx event 2019: VALUE-Dx kick off meeting and course
Year: 2019

Antimicrobial susceptibility of stenotrophomonas maltophilia isolated from respiratory specimens from a tertiary care center in Pakistan
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Efficacy of Ceftolozane/Tazobactam in Comparison with Piperacillin/Tazobactam in Severe Pseudomonas aeruginosa Pneumonia Swine Model
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019


Management of pseudomonas aeruginosa infection in children with long-term O2, long-term ventilation or tracheostomy
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016


Patients with no cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa: Role of inhaled colistin
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


LATE-BREAKING ABSTRACT: Molecular and Phenotypic Characters of Methicillin-resistant Staphylococcus aureus Isolates from Patients with Empyema Thoracis in Central Taiwan
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014


Emerging macrolide-resistant mycoplasma pneumoniae in Thailand
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Risk of Haemophilus Influenzae Infection in Patients with Chronic Obstructive Pulmonary Disease Using Inhaled Corticosteroids: A Cohort Study of 23,789 Outpatients.
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021